PetVivo Secures Canadian Medical Device Certification for Spryng
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 29 2026
0mins
Source: Newsfilter
- Regulatory Milestone: PetVivo's Spryng® with OsteoCushion® Technology has received medical device certification from Health Canada, marking a significant expansion of the company's international commercialization opportunities, with a launch expected in late July to meet market demand for innovative veterinary products.
- AI Platform Launch: In collaboration with Digital Landia, PetVivo launched the AgenticPet B2C solution, successfully onboarding over 1,000 users, demonstrating strong demand for AI-driven proactive pet healthcare, which is anticipated to enhance the value proposition of PetVivo's B2B veterinary platform.
- Cost Reduction: The PetVivo.ai SaaS platform achieved a 50% to 90% reduction in veterinary customer acquisition costs, lowering expenses from the typical $80-$400 per customer to under $43, significantly enhancing the company's competitiveness in the veterinary market.
- Strategic Acquisition: PetVivo's acquisition of PiezoBioMembrane integrates its patented biomaterials technology, expected to accelerate the development and commercialization of new products, driving long-term growth strategies in both animal and human healthcare sectors.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
